Journal
CANCER
Volume 129, Issue 5, Pages 668-670Publisher
WILEY
DOI: 10.1002/cncr.34594
Keywords
body composition; competing risks; prostate cancer; radiotherapy; sarcopenia
Categories
Ask authors/readers for more resources
Patients with nonmetastatic, high-risk prostate cancer have a higher likelihood of dying from causes unrelated to their cancer. Identifying patients at greater risk from competing risks is crucial for treatment decision-making.
Patients with nonmetastatic, high-risk prostate cancer are more likely to die of causes unrelated to their cancer. Identifying patients whose competing risks are a greater threat to their mortality has important implications for treatment decisions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available